.png?t=1508331115725&width=137&height=33&name=footer-logo%20(1).png "logo.png"){kind=small}
Poster presented by Alanna S. Ocampo-Pelland and Jonathan L. French at ACoP8. See the poster here.
1 Comment Click here to read/write comments
Topics: Methodology, Tools, and Computation, Oncology, Open Science
Click
here to access the slides from "
Points to Consider when Making Inferences about Covariates" presented by Marc Gastonguay, Ph.D. at ACoP8 Session Quantification of Covariate Effects for Labeling.
2 Comments Click here to read/write comments
Topics: Open Science
Slides Available: Dr. Marc Gastonguay's Sheiner Award lecture presented at ACoP8 on October 15, 2017. GastonguayISoPSheinerLecture2017final
0 Comments Click here to read/write comments
Topics: Open Science
Developing quantitative systems pharmacology (QSP) models is hard work, without doubt. Such projects often take months, if not years, and may include extensive experimental contributions and input from numerous discipline experts.
0 Comments Click here to read/write comments
Topics: Open Science
Tariffville, CT (August 25, 2017) - The Connecticut Technology Council (CTC) and Marcum LLP announced Metrum Research Group has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut. Metrum Research Group will be honored alongside 39 other TT40 companies at an awards ceremony on September 19th at the Oakdale Theatre in Wallingford. This marks the seventh time Metrum Research Group has been honored to be a Marcum Tech Top 40 recipient.
0 Comments Click here to read/write comments
Topics: Metrum News
Metrum Research Group is pleased to announce the appointment of Bill Knebel, Pharm.D., Ph.D. as President of the biomedical modeling and simulation services firm.
0 Comments Click here to read/write comments
Topics: Metrum News
by Tim Bergsma
Already widely received in the finance community, cloud computing is gaining acceptance in the pharmaceutical industry as well. At this year’s American Conference on Pharmacometrics, Metrum Research Group staff presented a poster on the topic, and helped lead a related panel discussion.
0 Comments Click here to read/write comments
“Prevention … we have never uttered that word at the Alzheimer’s Association International Conference, and here we actually highlighted three clinical trials in the planning for prevention of Alzheimer’s … “. This comment from Dr. Mario Carrillo gives voice to the enthusiasm and interest of the attendees at the standing-room-only Alzheimer’s Association International Conference session entitled, “Collaboration for Alzheimer’s Prevention: Common Issues Across Presymptomatic Treatment Trials”, in which the A4, API, and DIAN prevention trials were discussed.
0 Comments Click here to read/write comments
Topics: Neurodegenerative Diseases
For new developers, getting a package ready for building and submitting to CRAN is an expletive-filled, head-scratching experience to say the least. Trying to figure out the basics of what goes in depends and what goes in imports is a lost afternoon most of us would like back. Once that is understood, filling in relevant information to each field is a mundane task even for a well polished package developer. The out-of-the-box roxygen skeleton supplied by RStudio gives the bare bones road map of what should be part of function documentation:
0 Comments Click here to read/write comments
